Key result
Ribavirin triphosphates had no inhibitory effect on the purified HCV NS5B RNA-dependent RNA polymerase, indicating its therapeutic effect is not related to direct inhibition of the viral polymerase.
Ribavirin's therapeutic effect in HCV patients is not due to direct inhibition of the viral RNA-dependent RNA polymerase.
Challenges direct NS5B inhibition as ribavirin mechanism in HCV; leaves open alternative pathways for research.
Hepatitis C virus (HCV), the major causative agent of chronic and sporadic non-A, non-B hepatitis worldwide, is a distinct member of the Flaviviridae virus family. These viruses have in common a plus-strand RNA genome that is replicated in the cytoplasm of the infected cell via minus-strand RNA intermediates. Owing to the lack of reliable cell culture systems and convenient animal models for HCV, the mechanisms governing RNA replication are not known. As a first step towards the development of appropriate in vitro systems, we expressed the NS5B RNA-dependent RNA polymerase (RdRp) in insect cells, purified the protein to near homogeneity and studied its biochemical properties. It is a primer- and RNA template-dependent RNA polymerase able to copy long heteropolymeric templates without additional viral or cellular cofactors. We determined the optimal reaction parameters, the kinetic constants and the substrate specificity of the enzyme, which turned out to be similar to those described for the 3D polymerase of poliovirus. By analysing a series of nucleosidic and non-nucleosidic compounds for their effect on RdRp activity, we found that ribavirin triphosphates have no inhibitory effect, providing direct experimental proof that the therapeutic effect observed in patients is not related to a direct inhibition of the viral polymerase. Finally, mutation analysis was performed to map the minimal NS5B sequence required for enzymatic activity and to identify the 'classical' polymerase motifs important for template and NTP binding and catalysis.
No takes yet. Share an insight, caveat, or question.
Lohmann et al. (2000) studied Hepatitis C virus. Ribavirin triphosphates and other nucleosidic/non-nucleosidic compounds was evaluated on Inhibitory effect on NS5B RNA-dependent RNA polymerase activity. Ribavirin triphosphates had no inhibitory effect on the purified HCV NS5B RNA-dependent RNA polymerase, indicating its therapeutic effect is not related to direct inhibition of the viral polymerase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: